References
- Physicians’ Desk Reference®. Effexor. MICROMEDEX® Healthcare Series. Vol. 118, expires 12/2003.
- Fleisch MC, Blauer F, Gubler JG, Kuhn M, Scherer TA. Eosinophilic pneumonia and respiratory failure associated with venlafaxine. Eur Respir J 2000; 15: 205–8
- Drent M, Singh S, Gorgels APM, Hansell DM, Bekers O, Nicholson AG, et al. Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine. Am J Respir Crit Care Med 2003; 167: 958–61
- WHO database of adverse drug reactions. http://www.who-umc.org. Venlafaxine. Accessed 15 November 2004.
- Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3: 229–43
- Cazzola I, Matera MG. 5-HT modifiers as potential treatment of asthma. Trends Pharmacol Sci 2000; 21: 13–16
- Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: A double-blind, crossover, placebo-controlled study. J Clin Pharmacol 1998; 38: 918–25
- Brieva J, Wanner A. Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. J Appl Physiol 2001; 90: 665–9